欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5095/005
药品名称Sandostatin LAR-Monatsdepot 10 mg
活性成分
    • octreotide 10.0 mg
剂型Powder and solvent for suspension for injection
上市许可持有人Novartis Pharma GmbH Roonstr. 25 90429 Nürnberg Germany
参考成员国 - 产品名称Germany (DE)
Sandostatin LAR-Monatsdepot 10 mg
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Romania (RO)
    • Slovenia (SI)
    • Malta (MT)
许可日期2014/12/03
最近更新日期2024/04/19
药物ATC编码
    • H01CB02 octreotide
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase